skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Oxford University Press Journals Current remover assunto: Treatment Outcome remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis
The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The EGALITY study: a confirmatory, randomized, double‐blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate‐to‐severe chronic plaque‐type psoriasis

Griffiths, C.E.M. ; Thaçi, D. ; Gerdes, S. ; Arenberger, P. ; Pulka, G. ; Kingo, K. ; Weglowska, J. ; Hattebuhr, N. ; Poetzl, J. ; Woehling, H. ; Wuerth, G. ; Afonso, M.

British journal of dermatology (1951), 2017-04, Vol.176 (4), p.928-938 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
2
Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases
Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases

Vergidis, Paschalis ; Avery, Robin K. ; Wheat, L. Joseph ; Dotson, Jennifer L. ; Assi, Maha A. ; Antoun, Smyrna A. ; Hamoud, Kassem A. ; Burdette, Steven D. ; Freifeld, Alison G. ; McKinsey, David S. ; Money, Mary E. ; Myint, Thein ; Andes, David R. ; Hoey, Cynthia A. ; Kaul, Daniel A. ; Dickter, Jana K. ; Liebers, David E. ; Miller, Rachel A. ; Muth, William E. ; Prakash, Vidhya ; Steiner, Frederick T. ; Walker, Randall C. ; Hage, Chadi A.

Clinical infectious diseases, 2015-08, Vol.61 (3), p.409-417 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por
3
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures
Material Type:
Artigo 		Adicionar ao Meu Espaço

A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures

Ling, Stephanie F ; Yap, Chuan Fu ; Nair, Nisha ; Bluett, James ; Morgan, Ann W ; Isaacs, John D ; Wilson, Anthony G ; Hyrich, Kimme L ; Barton, Anne ; Plant, Darren

Rheumatology (Oxford, England), 2024-04, Vol.63 (4), p.1015-1021 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
4
Etanercept biosimilar SB4 in the treatment of plaque‐type psoriasis and psoriatic arthritis: a single‐centre, observational, retrospective, real‐life study
Etanercept biosimilar SB4 in the treatment of plaque‐type psoriasis and psoriatic arthritis: a single‐centre, observational, retrospective, real‐life study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Etanercept biosimilar SB4 in the treatment of plaque‐type psoriasis and psoriatic arthritis: a single‐centre, observational, retrospective, real‐life study

Giunta, A. ; Manfreda, V. ; Esposito, M. ; Del Duca, E. ; Bianchi, L.

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.1078-1079 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
5
A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study
A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

Vries, A.C.Q. ; Thio, H.B. ; Kort, W.J.A. ; Opmeer, B.C. ; Stok, H.M. ; Jong, E.M.G.J. ; Horvath, B. ; Busschbach, J.J.V. ; Nijsten, T.E.C. ; Spuls, Ph.I.

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.624-633 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
6
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis
Material Type:
Artigo 		Adicionar ao Meu Espaço

52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis

Emery, Paul ; Vencovský, Jirí ; Sylwestrzak, Anna ; Leszczynski, Piotr ; Porawska, Wieslawa ; Baranauskaite, Asta ; Tseluyko, Vira ; Zhdan, Vyacheslav M ; Stasiuk, Barbara ; Milasiene, Roma ; Barrera Rodriguez, Aaron Alejandro ; Cheong, Soo Yeon ; Ghil, Jeehoon

Rheumatology (Oxford, England), 2017-12, Vol.56 (12), p.2093-2101 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
7
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies
Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies

Kimball, A.B. ; Papp, K.A. ; Reich, K. ; Gooderham, M. ; Li, Q. ; Cichanowitz, N. ; La Rosa, C. ; Blauvelt, A.

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1359-1368 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
8
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Vojinović, Jelena ; Foeldvari, Ivan ; Dehoorne, Joke ; Panaviene, Violeta ; Susic, Gordana ; Horneff, Gerd ; Stanevicha, Valda ; Kobusinska, Katarzyna ; Zuber, Zbigniew ; Dobrzyniecka, Bogna ; Akikusa, Jonathan ; Avcin, Tadej ; Borlenghi, Cecilia ; Arthur, Edmund ; Tatulych, Svitlana Y ; Zang, Chuanbo ; Tsekouras, Vassilis ; Vlahos, Bonnie ; Martini, Alberto ; Ruperto, Nicolino

Rheumatology (Oxford, England), 2024-01, Vol.63 (1), p.140-148 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
9
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry

Gisondi, P. ; Bianchi, L. ; Calzavara‐Pinton, P. ; Conti, A. ; Chiricozzi, A. ; Fimiani, M. ; Pellegrino, M. ; Giunta, A. ; Prignano, F. ; Tiberio, R. ; Venturini, M. ; Girolomoni, G.

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.409-410 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
10
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial
A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Papp, K. ; Gottlieb, A. ; Reich, K. ; Maari, C. ; Gordon, K.B. ; Lima, R.G. ; Elmaraghy, H. ; Gallo, G. ; Renda, L. ; Park, S.Y. ; Burge, R. ; Bagel, J. ; Vender, Ronald ; Hong, Chih‐Ho ; Langley, Richard L. ; Albrecht, Lorne ; Guenther, Lyn ; Papp, Kim ; Singh Ohson, Kamal K. ; Barber, Kirk ; Lynde, Charles ; Gupta, Aditya ; Rosoph, Leslie ; Gauthier, Jean‐Sébastien ; Gooderham, Melinda ; Wasel, Norman ; Wiseman, Marni ; Greenstein, David ; Jarell, Abel ; Moon, Charles ; Bukhalo, Michael ; Moore, Angela ; Hamilton, Tiffani K. ; Gewirtzman, Aron ; Hazan, Lydie ; Crowley, Jeffrey ; Teller, Craig ; Smith, Stacy R. ; Christine Lee, M. ; Lee, Patricia ; Dhawan, Sunil ; Leonardi, Craig ; Jesus, Amarilis Perez‐De ; McFalda, Wendy ; Fretzin, Scott ; Schlesinger, Todd ; Gottlieb, Scott ; Jenkin, Peter ; Gharib, Rola ; Davis, Steven ; Draelos, Zoe Diana ; Godwin, Lloyd ; Landis, Megan ; Sanchez‐Rivera, Samuel ; Fivenson, David ; Kerdel, Francisco ; Forman, Seth B. ; Gonzalez‐Chavez, Jose ; Boyce, Brent ; Stein‐Gold, Linda ; Hudson, Charles ; Brown, Constance ; Coggi, James ; Feser, Christina ; McCune, Mark ; Madkan, Vandana ; Shipp, Dana Maxwell ; Soto‐Raices, Oscar ; Cather, Jennifer ; Miller, Scott ; Scott, John ; Young, Douglas ; Yokum, Kelley ; McCracken, Gary ; McElgunn, Patrick ; Herrmann, James ; Appel, James ; Barranco, Elizabeth ; Cauthen, Ashley ; Sadick, Neil ; De La Torre, Eneida ; Taylor, Kelly ; Harris, Holly Hake ; Soung, Jennifer ; Dimitropoulos, Vassilios ; Miller, Stephen ; Barnes, Cathy ; Jumean‐Haddad, Rawan ; Guenthner, Scott ; Laquer, Vivian ; Jacobs, Shahram ; Nahm, Walter ; Korman, Neil ; Elewski, Boni ; Ferris, Laura ; Duffin, Kristina Callis ; Pariser, David ; Johnson, Brian ; Travers, Jeffrey ; Fried, Richard

British journal of dermatology (1951), 2020-06, Vol.182 (6), p.1348-1358 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (247)

Data de Publicação 

De até
Refinar
  1. Antes de2004  (8)
  2. 2004Até2008  (61)
  3. 2009Até2013  (92)
  4. 2014Até2019  (67)
  5. Após 2019  (21)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.